BioCentury
ARTICLE | Finance

Diagnostics companies survive Monday’s market rout

March 10, 2020 1:14 AM UTC

Large diagnostics companies with COVID-19 testing capabilities weathered Monday’s sell-off better than biotechs developing therapies and vaccines for the virus. Major indexes fell due to continued fears over the COVID-19 outbreak and a steep drop in oil prices.

The Dow Jones Industrial Average and the S&P 500 both fell nearly 8% Monday; the NASDAQ Composite ended down 7.3%...